Trellis Bioscience
South San Francisco, United States· Est. 2018
Trellis Bioscience Announces Clinical Proof of Concept in reducing biofilm burden in Prosthetic Joint Infections with a native human monoclonal antibody TRL1068 (View Press Release)
Private Company
Total funding raised: $25M
About
Trellis Bioscience Announces Clinical Proof of Concept in reducing biofilm burden in Prosthetic Joint Infections with a native human monoclonal antibody TRL1068 (View Press Release)
AntibodiesBiologics
Funding History
1Total raised:$25M
Series A$25MMar 15, 2021